InMed Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Vancouver, Canada, focused on the research and development of innovative cannabinoid-based therapies for various medical conditions. Leveraging its proprietary biosynthesis technology, InMed aims to address unmet medical needs by creating pharmaceutical-grade cannabinoids for use in diverse therapeutic applications. With a robust pipeline of drug candidates undergoing clinical trials, the company is positioned to capitalize on the growing global interest in cannabinoid therapies and advance the science of cannabinoid medicine.